Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
OWMClass II

Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

21 CFR 866.6040 / Immunology

OWM is the FDA product code for Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers, a class II device type, regulated under 21 CFR 866.6040. FDA's definition for this code reads: "Determines rate of increase of total prostate specific antigen at ultrasensitive concentration levels (picogram/ml serum), and identifies those patients following prostatectomies which are at reduced risk for recurrence of prostate cancer". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.

Classification record

Product code
OWM
Device name
Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
FDA definition
Determines rate of increase of total prostate specific antigen at ultrasensitive concentration levels (picogram/ml serum), and identifies those patients following prostatectomies which are at reduced risk for recurrence of prostate cancer.
Regulation
21 CFR 866.6040
Device class
Class II
Review panel
Immunology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
1
Ingested recalls
0

Clearances, product code OWM

By decision year
1 clearance under product code OWM with a decision year between 2011 and 2011, 2011 the highest year at 1.
Show the numbers
510(k) clearances under FDA product code OWM by decision year
YearClearances
20111

Applicants with the most clearances

Product code OWM
Applicants holding the most 510(k) clearances under product code OWM
ApplicantClearances
Iris Molecular Diagnostics1

Companies listing this code with FDA

Companies whose registered establishments list this code